Article: article from journal or magazin.
Case report (case report): feedback on an observation with a short commentary.
Effects of the long-acting somatostatin analogue SMS 201-995 in an infant with intractable diarrhea.
Helvetica Paediatrica Acta
Publication types: Case Reports ; Journal ArticlePublication Status: ppublish
The long-acting somatostatin analogue SMS 201-995 was administered to a six-month-old infant with intractable diarrhea after failure of conventional treatment. During eight weeks of treatment, the secretory component of the diarrhea was positively influenced with a reduction of daily stool weight and stool sodium concentration. Plasma levels of growth hormone were markedly, and levels of insulin, IGF I, gastrin, pancreatic polypeptide, VIP, and neurotensin moderately decreased. Linear growth was also inhibited. The patient unexpectedly died from fulminant colitis at a time, when the dosage had been reduced from 18 to 3.5 micrograms/kg/day. The relationship, if any, between therapy with SMS 201-995 and the colitis remained unclear. It is concluded that SMS 201-995 can be effective in reducing secretory diarrhea in infants. However, further studies are necessary to assess the safety of its administration in this age group.
Antidiarrheals/therapeutic use, Diarrhea, Infantile/drug therapy, Hormones/blood, Humans, Infant, Newborn, Male, Octreotide/administration & dosage, Octreotide/pharmacology, Receptors, Opioid
Web of science
Last modification date